The combined effects of financial and market indicators on the valuation of new listings: evidence from the biopharmaceutical sector

HIGHLIGHTS

• What: By analysing the impact of financial data (e_g profitability, debt level and cash flow situation) and market data (e_g pre-IPO market sentiment, macroeconomic indicators and industry growth rates) on IPO valuation, this study aims to reveal the specific mechanisms by which these factors act on the valuation of newly listed companies . To prevent the influence of abnormal or missing sample data on the experimental analyses and results, this paper selected 17 sample companies from 386 biopharmaceutical companies, and the statistical data were obtained from the Wind Information financial terminal database. This analysis shows that while . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.